RIGL vs. AYA.TO
RIGL (Rigel Pharmaceuticals, Inc.) and AYA.TO (Aya Gold & Silver Inc.) are both stocks. RIGL operates in Biotechnology (Healthcare), while AYA.TO operates in Other Precious Metals & Mining (Basic Materials). Over the past 10 years, RIGL returned 2.33%/yr vs 43.53%/yr for AYA.TO. At a 0.07 correlation, their price movements are largely independent.
Performance
RIGL vs. AYA.TO - Performance Comparison
Loading charts...
Different Trading Currencies
RIGL is traded in USD, while AYA.TO is traded in CAD. To make them comparable, the AYA.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, RIGL achieves a -29.77% return, which is significantly lower than AYA.TO's 21.96% return. Over the past 10 years, RIGL has underperformed AYA.TO with an annualized return of 2.33%, while AYA.TO has yielded a comparatively higher 43.53% annualized return.
RIGL
- 1D
- 0.50%
- 1M
- 15.51%
- YTD
- -29.77%
- 6M
- -30.69%
- 1Y
- 39.97%
- 3Y*
- 23.16%
- 5Y*
- -5.96%
- 10Y*
- 2.33%
AYA.TO
- 1D
- 1.90%
- 1M
- -9.63%
- YTD
- 21.96%
- 6M
- 37.96%
- 1Y
- 71.11%
- 3Y*
- 36.55%
- 5Y*
- 20.58%
- 10Y*
- 43.53%
RIGL vs. AYA.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | -29.77% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
AYA.TO Aya Gold & Silver Inc. | 21.96% | 91.62% | 1.97% | 10.27% | -11.18% | 148.17% | 102.23% | 6.48% | 7.43% | 214.13% |
Correlation
The correlation between RIGL and AYA.TO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2008 | 0.07 |
Fundamentals
RIGL:
$592.15M
AYA.TO:
CA$3.62B
RIGL:
$19.21
AYA.TO:
CA$0.60
RIGL:
1.57
AYA.TO:
40.54
RIGL:
0.00
AYA.TO:
0.08
RIGL:
1.90
AYA.TO:
12.31
RIGL:
1.48
AYA.TO:
7.90
RIGL:
$299.77M
AYA.TO:
CA$283.62M
RIGL:
$279.95M
AYA.TO:
CA$155.19M
RIGL:
$125.80M
AYA.TO:
CA$167.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RIGL vs. AYA.TO — Risk / Return Rank
RIGL
AYA.TO
RIGL vs. AYA.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and Aya Gold & Silver Inc. (AYA.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RIGL | AYA.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.34 | ||
| Sortino ratioReturn per unit of downside risk | -0.16 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.20 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.80 | 1.72 | -0.91 |
| Martin ratioReturn relative to average drawdown | 1.41 | 4.44 | -3.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RIGL | AYA.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.58 | 0.91 | -0.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.07 | 0.31 | -0.38 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.03 | 0.56 | -0.53 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | 0.19 | -0.32 |
Drawdowns
RIGL vs. AYA.TO - Drawdown Comparison
The maximum RIGL drawdown since its inception was -99.37%, which is greater than AYA.TO's maximum drawdown of -87.28%. Use the drawdown chart below to compare losses from any high point for RIGL and AYA.TO.
Loading charts...
Drawdown Indicators
| RIGL | AYA.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -87.28% | -12.09% |
Max Drawdown (1Y)Largest decline over 1 year | -50.08% | -41.64% | -8.44% |
Max Drawdown (3Y)Largest decline over 3 years | -57.75% | -55.59% | -2.16% |
Max Drawdown (5Y)Largest decline over 5 years | -85.24% | -56.77% | -28.47% |
Max Drawdown (10Y)Largest decline over 10 years | -86.40% | -74.18% | -12.22% |
Current DrawdownCurrent decline from peak | -97.18% | -19.00% | -78.18% |
Average DrawdownAverage peak-to-trough decline | -90.92% | -40.13% | -50.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.34% | 16.06% | +12.28% |
Volatility
RIGL vs. AYA.TO - Volatility Comparison
The current volatility for Rigel Pharmaceuticals, Inc. (RIGL) is 18.26%, while Aya Gold & Silver Inc. (AYA.TO) has a volatility of 29.17%. This indicates that RIGL experiences smaller price fluctuations and is considered to be less risky than AYA.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RIGL | AYA.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.26% | 29.17% | -10.91% |
Volatility (6M)Calculated over the trailing 6-month period | 38.39% | 57.79% | -19.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.94% | 78.30% | -8.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.50% | 67.78% | +17.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 82.83% | 78.18% | +4.65% |
Dividends
RIGL vs. AYA.TO - Dividend Comparison
Neither RIGL nor AYA.TO has paid dividends to shareholders.
Financials
RIGL vs. AYA.TO - Financials Comparison
This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and Aya Gold & Silver Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RIGL vs. AYA.TO - Profitability Comparison
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
AYA.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported a gross profit of 82.27M and revenue of 115.35M. Therefore, the gross margin over that period was 71.3%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
AYA.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported an operating income of 76.31M and revenue of 115.35M, resulting in an operating margin of 66.2%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
AYA.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported a net income of 47.54M and revenue of 115.35M, resulting in a net margin of 41.2%.
Frequently Asked Questions
RIGL and AYA.TO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for RIGL and AYA.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer